Bioventus (BVS) Payables (2020 - 2025)
Historic Payables for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $26.6 million.
- Bioventus' Payables rose 5816.37% to $26.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.6 million, marking a year-over-year increase of 5816.37%. This contributed to the annual value of $23.7 million for FY2024, which is 283.01% up from last year.
- Per Bioventus' latest filing, its Payables stood at $26.6 million for Q3 2025, which was up 5816.37% from $24.2 million recorded in Q2 2025.
- Bioventus' 5-year Payables high stood at $41.4 million for Q3 2023, and its period low was $9.9 million during Q3 2021.
- Its 5-year average for Payables is $22.2 million, with a median of $22.5 million in 2022.
- As far as peak fluctuations go, Bioventus' Payables soared by 28251.92% in 2021, and later crashed by 4182.1% in 2024.
- Over the past 5 years, Bioventus' Payables (Quarter) stood at $16.9 million in 2021, then skyrocketed by 116.95% to $36.7 million in 2022, then tumbled by 37.22% to $23.0 million in 2023, then increased by 2.83% to $23.7 million in 2024, then grew by 12.49% to $26.6 million in 2025.
- Its Payables was $26.6 million in Q3 2025, compared to $24.2 million in Q2 2025 and $19.2 million in Q1 2025.